IMR Press / FBL / Volume 22 / Issue 3 / DOI: 10.2741/4492

Frontiers in Bioscience-Landmark (FBL) is published by IMR Press from Volume 26 Issue 5 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with Frontiers in Bioscience.

Review

Interventions in Parkinson's disease: Role of executive function

Show Less
1 Department of Neurology, Henry Ford Hospital, Detroit, MI, USA
2 Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA
Front. Biosci. (Landmark Ed) 2017, 22(3), 416–427; https://doi.org/10.2741/4492
Published: 1 January 2017
Abstract

The cortico-striatal network plays a major role in executive functions (EF), and is believed to play a role in the pathophysiology of Parkinson's disease (PD). However, the tools to assess EF are limited. This review assesses the impact of all PD interventions, namely, pharmacotherapy, physical exercise and Deep Brain Stimulation (DBS) surgery on EF. The effect of PD pharmacotherapy varies with the drug class, neuropsychological test used and the affected dopamine receptor family. There appears to be a benefit of aerobic exercise on EF, including judgment and attention. The effect of Deep Brain Stimulation on EF might vary with site of brain stimulation, the neuropsychological test performed and the pre-operative cognitive state. The effect of EF on underlying manifestations and as a factor in the pathway to the motor benefit needs to be better assessed with more accurate tests that focus on motor component of EF.

Keywords
Executive Function
Parkinson's Disease
DBS
Neuroepidemiology
Review
Share
Back to top